Mindestbestellung 120 EUR Kostenlose Lieferung ab 250 EUR Bereit zur Abholung dead drop: in 5 Min. abholen Kostenloser Versand ab 250 EUR Aktionen

Substanzen · Benzodiazepine und Thienodiazepine

Desalkylgidazepam

C17H13ClN4 CAS 28981-97-7 Nur für analytische Forschungszwecke — nicht für den menschlichen Verzehr
Bevorzugter Name
Desalkylgidazepam
IUPAC-Name
8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
CAS-Nummer der Stammverbindung (Referenz)
28981-97-7
Summenformel
C17H13ClN4
Molekulargewicht
308.8 g/mol
InChIKey
VREFGVBLTWBCJP-UHFFFAOYSA-N
PubChem
CID 2118
Quelle
PubChem
Geprüfte Synonyme und Katalogkürzel
Bromonordiazepam Gidazepam M1

Passende Artikel im aktuellen Shop-Katalog

Geprüftes Pharmakologie- & Toxikologie-Dossier

Desalkylgidazepam

Daytime-Leaning Anxiolytic Metabolite (Desalkylgidazepam) 1,4-Benzodiazepine
Geprüfte PubChem- & CAS-Identität C17H13ClN4 · CAS 28981-97-7 · CID 2118
Kalibrierte Lieferform Präzisionstabletten · 1 Tablette = 1 mg
≥98 % analytische Reinheit geprüft 308.8 g/mol
WHO-, PubMed- & PubChem-Quellen 2 cited records

Rezeptor-Telemetrie & Wirkmechanismus

GABAₐ α₂/α₃ Anxiolysis & Myorelaxation High PAM
GABAₐ α₁ Hypnotic / Sedative Drive Moderate-High
GABAₐ α₅ Amnestic / Cognitive Modulation Moderate

Active N-desalkyl metabolite of gidazepam (bromonordiazepam) acting as a partial/selective GABA-A modulator with lower hypnotic sedation than triazolobenzodiazepines.

Biotransformation & Active Metabolites

Slow hepatic elimination with an extended ~80-hour plasma half-life.

Zeitliche Pharmakokinetik

Daytime-Leaning Anxiolytic Metabolite (Desalkylgidazepam) — Mild per-milligram potency (1 tablet = 1 mg; common literature range 3–6 mg) with gentle anxiolysis and long elimination half-life (~80 h).

  1. Onset 30–75 min
  2. Peak Window 2–4 h
  3. Total Window 8–14 h
  4. Residual / Half-Life 24–60 h residual (T1/2 ~80 h)

Mild per-milligram potency (1 tablet = 1 mg; common literature range 3–6 mg) with gentle anxiolysis and long elimination half-life (~80 h).

Quantitatives Wirkungsspektrum (Literaturdaten)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
1–2 mg
Cognitive & Sensory

Subtle threshold receptor activity (Daytime-Leaning Anxiolytic Metabolite (Desalkylgidazepam)).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
2–3 mg
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
3–6 mg
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
6–9 mg
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
12+ mg
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Wechselwirkungsmatrix — Niemals kombinieren

Lebensgefahr — Niemals kombinieren

Opioids (O-DSMT, tramadol, morphine, oxycodone, fentanyl)

Synergistic brainstem respiratory depression causing unconsciousness and fatal respiratory arrest.

Alcohol, GHB/GBL, and Barbiturates

Extreme CNS depression, complete anterograde amnesia, loss of airway reflexes, and fatal aspiration.

Hohes Risiko — Vermeiden

Dissociatives (Ketamine, 2-FDCK, DCK, O-PCE, MXE)

Unpredictable sedation, severe motor ataxia, blackout, and emesis aspiration hazard.

Vorsicht / Abschwächung

CYP3A4 inhibitors (grapefruit juice, ketoconazole) & Stimulants

CYP3A4 inhibitors prolong plasma half-life; stimulants mask sedation until they wear off.

Isomeren- & Strukturvergleich

Mild per-milligram potency (1 tablet = 1 mg; common literature range 3–6 mg) with gentle anxiolysis and long elimination half-life (~80 h).

Stabilität & Lagerung

Form: Precision-pressed 1 mg analytical tablets (1 tablet = 1 mg). · Parent molecule soluble in ethanol, propylene glycol, and DMSO; sparingly soluble in water.

Store sealed in a cool, dry, light-protected container away from humidity.

Cross-Tolerance & Dependence Profile

Complete cross-tolerance across all GABA-A benzodiazepines/thienodiazepines. Rapid physical dependence develops with continuous daily exposure; abrupt cessation after prolonged intake can trigger life-threatening rebound seizures and delirium.

Analytische & toxikologische Monographie

Desalkylgidazepam (8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine; CAS 28981-97-7, PubChem CID 2118) is a 1,4-benzodiazepine reference compound (C17H13ClN4, 308.8 g/mol) classified pharmacologically as a Daytime-Leaning Anxiolytic Metabolite (Desalkylgidazepam). Active N-desalkyl metabolite of gidazepam (bromonordiazepam) acting as a partial/selective GABA-A modulator with lower hypnotic sedation than triazolobenzodiazepines. Slow hepatic elimination with an extended ~80-hour plasma half-life. In published observational and toxicological literature, threshold response is noted at 1–2 mg, light range at 2–3 mg, common reference range at 3–6 mg, strong intensity at 6–9 mg, and heavy/adverse territory at 12+ mg, with an onset of 30–75 min, peak window of 2–4 h, and total duration of 8–14 h (24–60 h residual (T1/2 ~80 h)). Mild per-milligram potency (1 tablet = 1 mg; common literature range 3–6 mg) with gentle anxiolysis and long elimination half-life (~80 h). Critical contraindications include Opioids (O-DSMT, tramadol, morphine, oxycodone, fentanyl), Alcohol, GHB/GBL, and Barbiturates.

Chemische Struktur und Molekülprofil

Desalkylgidazepam (8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine) ist eine Referenzverbindung aus der Stoffklasse Benzodiazepine und Thienodiazepine mit der Summenformel C17H13ClN4 und einer molaren Masse von 308.8 g/mol. Die Stammverbindung wird unter der CAS-Nummer 28981-97-7 sowie in der NCBI-PubChem-Datenbank unter CID 2118 geführt (Standard-InChIKey: VREFGVBLTWBCJP-UHFFFAOYSA-N).

Quellen

Referenztoxikologie und Sicherheitsprofil

Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört Desalkylgidazepam zur chemischen Klasse Benzodiazepine und Thienodiazepine. Diazepin-Referenzverbindung mit ausgeprägtem Risiko synergistischer Atemdepression in Kombination mit Opioiden, Alkohol oder anderen Sedativa. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.

Quellen

Analytischer Verwendungszweck und Laborhinweis

Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.

Quellen